Chemistry Wealth Management’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
5,482
-333
-6% -$60.5K 0.17% 80
2026
Q1
$1.1M Sell
5,815
-612
-10% -$130K 0.19% 75
2025
Q4
$1.47M Buy
6,427
+125
+2% +$27.5K 0.28% 58
2025
Q3
$1.25M Sell
6,302
-276
-4% -$54.9K 0.24% 66
2025
Q2
$1.3M Buy
6,578
+377
+6% +$73.1K 0.28% 63
2025
Q1
$1.27M Buy
6,201
+1,262
+26% +$276K 0.3% 57
2024
Q4
$1.13M Sell
4,939
-8
-0.2% -$1.97K 0.27% 59
2024
Q3
$1.38M Sell
4,947
-18
-0.4% -$4.76K 0.33% 53
2024
Q2
$1.24M Buy
4,965
+225
+5% +$56.8K 0.32% 50
2024
Q1
$1.18M Hold
4,740
0.32% 51
2023
Q4
$1.1M Buy
+4,740
New +$1.01M 0.33% 53

Other funds holding DHR

Chemistry Wealth Management's DHR Position: Q2 2026 in Review

Chemistry Wealth Management reduced its Danaher (DHR) stake by 5.7% in Q2 2026, selling an estimated $60.5K and leaving 5,482 shares worth $1.04M. The position accounts for 0.17% of the portfolio, ranked #80.

Chemistry Wealth Management first reported a position in DHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.47M in Q4 2025. 965 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Chemistry Wealth Management held 5,482 shares of Danaher worth $1.04M as of Q2 2026.
  • Chemistry Wealth Management sold 333 Danaher shares in Q2 2026, an estimated $60.5K.
  • Danaher made up 0.17% of Chemistry Wealth Management's portfolio in Q2 2026, its #80 holding.
  • Chemistry Wealth Management first reported a position in Danaher in Q4 2023 and has held it in 11 quarters since.
  • Chemistry Wealth Management's Danaher position peaked at $1.47M in Q4 2025.
  • 965 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.